Annual Shareholders Equity
$571.55 M
+$239.34 M+72.04%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual stockholders equity is $571.55 million, with the most recent change of +$239.34 million (+72.04%) on December 31, 2024.
- During the last 3 years, KROS annual shareholders equity has risen by +$328.38 million (+135.04%).
- KROS annual shareholders equity is now at all-time high.
Performance
KROS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$571.55 M
+$38.72 M+7.27%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly stockholders equity is $571.55 million, with the most recent change of +$38.72 million (+7.27%) on December 31, 2024.
- Over the past year, KROS quarterly shareholders equity has stayed the same.
- KROS quarterly shareholders equity is now at all-time high.
Performance
KROS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KROS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.0% | 0.0% |
| 3 y3 years | +135.0% | +135.0% |
| 5 y5 years | +10000.0% | +10000.0% |
KROS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +135.0% | at high | +170.6% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Keros Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $571.55 M(+72.0%) | $571.55 M(+7.3%) |
| Sep 2024 | - | $532.84 M(+26.6%) |
| Jun 2024 | - | $420.92 M(-7.3%) |
| Mar 2024 | - | $453.95 M(+36.6%) |
| Dec 2023 | $332.21 M(+19.7%) | $332.21 M(+12.3%) |
| Sep 2023 | - | $295.84 M(-9.3%) |
| Jun 2023 | - | $326.26 M(-8.1%) |
| Mar 2023 | - | $354.98 M(+28.0%) |
| Dec 2022 | $277.42 M | $277.42 M(+15.1%) |
| Sep 2022 | - | $241.03 M(+14.1%) |
| Jun 2022 | - | $211.21 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $223.49 M(-8.1%) |
| Dec 2021 | $243.17 M(-7.1%) | $243.17 M(+11.3%) |
| Sep 2021 | - | $218.48 M(-7.3%) |
| Jun 2021 | - | $235.66 M(-5.1%) |
| Mar 2021 | - | $248.37 M(-5.1%) |
| Dec 2020 | $261.72 M(>+9900.0%) | $261.72 M(+100.2%) |
| Sep 2020 | - | $130.76 M(-7.5%) |
| Jun 2020 | - | $141.36 M(+178.0%) |
| Mar 2020 | - | $50.85 M(>+9900.0%) |
| Dec 2019 | $495.00 K(-96.1%) | $495.00 K |
| Dec 2018 | $12.76 M | - |
FAQ
- What is Keros Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Keros Therapeutics?
- What is Keros Therapeutics annual shareholders equity year-on-year change?
- What is Keros Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Keros Therapeutics?
- What is Keros Therapeutics quarterly shareholders equity year-on-year change?
What is Keros Therapeutics annual stockholders equity?
The current annual shareholders equity of KROS is $571.55 M
What is the all time high annual shareholders equity for Keros Therapeutics?
Keros Therapeutics all-time high annual stockholders equity is $571.55 M
What is Keros Therapeutics annual shareholders equity year-on-year change?
Over the past year, KROS annual stockholders equity has changed by +$239.34 M (+72.04%)
What is Keros Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of KROS is $571.55 M
What is the all time high quarterly shareholders equity for Keros Therapeutics?
Keros Therapeutics all-time high quarterly stockholders equity is $571.55 M
What is Keros Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, KROS quarterly stockholders equity has changed by $0.00 (0.00%)